ASCO 2026: A potential functional cure in endometrial cancer...
For GSK, ASCO 2026 was about long-term follow-up data, with new data from ongoing trials of Jemperli and Blenrep.
Newsletters and Deep Dive digital magazine
For GSK, ASCO 2026 was about long-term follow-up data, with new data from ongoing trials of Jemperli and Blenrep.
A half-day symposium – titled Women’s Health: From Intractable to Investable – was held in London on 11th June, organised by Weatherden.
Through Inventus Control, Inventus delivers a dedicated Mobile Device Management (MDM) platform for the life sciences sector.
Engagement solutions can tap into long-lasting patient motivations that sustain behaviour.
Editor's Picks
Newsletters and Deep Dive
digital magazine
Editor's Picks